Dr. Vivek Subbiah is the Chief of Early Phase Drug Development at Sarah Cannon Research Institute. As a leading expert in early drug development, he has served as principal investigator in over ...

Vivek Subbiah, an oncologist and medical director of the Clinical Center for Targeted Therapy at MD Anderson Cancer Center in Houston, Texas, anchored the discussion around the vital needs of ...

announced today that scientific leaders Dr. Vivek Subbiah, Prof. Michael Dustin, and Dr. Robert Lutz will join their world-class advisory team. These appointments bring extensive expertise to the ...